The GPCR adaptor protein Norbin regulates S1PR1 trafficking and the morphology, cell cycle and survival of PC12 cells
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 4,29 MB, PDF-dokument
Originalsprog | Engelsk |
---|---|
Artikelnummer | 18237 |
Tidsskrift | Scientific Reports |
Vol/bind | 13 |
Udgave nummer | 1 |
Antal sider | 13 |
ISSN | 2045-2322 |
DOI | |
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
We gratefully acknowledge the support of Professor Rod Hubbard from the University of York and Vernalis in the initiation and oversight of this project. We thank Dr Simon Andrews, Head of the Babraham Bioinformatics facility, and the staff of the Babraham Imaging and Flow Cytometry facilities for their dedicated and highly skilled support. This research was funded by Institute Strategic Programme Grant BB/P013384/1 from the BBSRC to the Signalling Programme at the Babraham Institute. V. B. I. J. was supported by a Peter and Emma Thomsen Scholarship. E.H. received an iCASE studentship from the BBSRC in collaboration with Vernalis (R&D) Ltd. E.T. received an iCASE studentship from the BBSRC in collaboration with AstraZeneca-MedImmune. S.A.C. is the recipient of a targeted PhD studentship from the MRC.
Funding Information:
We gratefully acknowledge the support of Professor Rod Hubbard from the University of York and Vernalis in the initiation and oversight of this project. We thank Dr Simon Andrews, Head of the Babraham Bioinformatics facility, and the staff of the Babraham Imaging and Flow Cytometry facilities for their dedicated and highly skilled support. This research was funded by Institute Strategic Programme Grant BB/P013384/1 from the BBSRC to the Signalling Programme at the Babraham Institute. V. B. I. J. was supported by a Peter and Emma Thomsen Scholarship. E.H. received an iCASE studentship from the BBSRC in collaboration with Vernalis (R&D) Ltd. E.T. received an iCASE studentship from the BBSRC in collaboration with AstraZeneca-MedImmune. S.A.C. is the recipient of a targeted PhD studentship from the MRC.
Publisher Copyright:
© 2023, Springer Nature Limited.
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
ID: 371922552